RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.
作者信息
Kulkarni Amit A, Boora Ganesh, Kanwar Rahul, Ruddy Kathryn J, Banck Michaela S, Le-Lindqwister Nguyet, Therneau Terry M, Loprinzi Charles L, Beutler Andreas S
机构信息
a Department of Medical Oncology , Mayo Clinic , Rochester , MN.
出版信息
Acta Oncol. 2015;54(8):1227-9. doi: 10.3109/0284186X.2014.985388. Epub 2014 Dec 31.
Abstract
摘要
相似文献
1
RWDD3 and TECTA variants not linked to paclitaxel induced peripheral neuropathy in North American trial Alliance N08C1.在北美试验联盟N08C1中，RWDD3和TECTA变异与紫杉醇诱导的周围神经病变无关。
Acta Oncol. 2015;54(8):1227-9. doi: 10.3109/0284186X.2014.985388. Epub 2014 Dec 31.
2
GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.在斯堪的纳维亚卵巢癌患者中，无法证实基于全基因组关联研究（GWAS）的RWDD3和TECTA基因变异与紫杉醇诱导的神经病变之间的关联。
Acta Oncol. 2013 May;52(4):871-4. doi: 10.3109/0284186X.2012.707787. Epub 2012 Aug 9.
3
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).夏科-马里-图思病基因ARHGEF10与NCCTG N08CA（联盟）中紫杉醇诱导的周围神经病变的关联。
J Neurol Sci. 2015 Oct 15;357(1-2):35-40. doi: 10.1016/j.jns.2015.06.056. Epub 2015 Jun 27.
4
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).在试验NCCTG N08C1（联盟）中对与紫杉醇神经病变相关的候选单核苷酸变异进行检测。
Cancer Med. 2016 Apr;5(4):631-9. doi: 10.1002/cam4.625. Epub 2016 Jan 14.
5
Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).由 CALGB 40101（Alliance）中的轴突生长基因集驱动的紫杉醇诱导感觉周围神经病的多基因遗传。
Pharmacogenomics J. 2014 Aug;14(4):336-42. doi: 10.1038/tpj.2014.2. Epub 2014 Feb 11.
6
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.全基因组关联研究鉴定出 Ephrin 型 A 受体在紫杉醇诱导的周围感觉神经病中的作用。
J Med Genet. 2013 Sep;50(9):599-605. doi: 10.1136/jmedgenet-2012-101466. Epub 2013 Jun 17.
7
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.细胞系和临床试验全基因组分析的整合支持紫杉醇诱导感觉周围神经病变的多基因结构。
Clin Cancer Res. 2013 Jan 15;19(2):491-9. doi: 10.1158/1078-0432.CCR-12-2618. Epub 2012 Nov 30.
8
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.一项全基因组关联研究鉴定了用于 CALGB 40101 的紫杉醇诱导的感觉外周神经病变的新的基因座。
Clin Cancer Res. 2012 Sep 15;18(18):5099-109. doi: 10.1158/1078-0432.CCR-12-1590. Epub 2012 Jul 27.
9
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia.ABCB1基因分型与紫杉醇介导的周围神经病变及中性粒细胞减少的相关性
Eur J Cancer. 2006 Nov;42(17):2893-6. doi: 10.1016/j.ejca.2006.06.017. Epub 2006 Sep 6.
10
Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.除CYP2C8*3之外的基因异质性并不能解释对紫杉醇诱导的神经病变的不同敏感性。
Breast Cancer Res Treat. 2014 May;145(1):245-54. doi: 10.1007/s10549-014-2910-1. Epub 2014 Apr 6.
引用本文的文献
1
A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.一种用于发现紫杉醇诱导的周围神经病（TIPN）生物标志物的多模态方法：研究方案。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221127169. doi: 10.1177/15330338221127169.
2
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity.个体化医学时代的副作用管理：化疗诱导的周围神经毒性。
Methods Mol Biol. 2022;2547:95-140. doi: 10.1007/978-1-0716-2573-6_5.
3
Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes.奥沙利铂在患有夏科-马里-图思病基因罕见变异患者中的神经安全性。
J Neurol Sci. 2020 Apr 15;411:116687. doi: 10.1016/j.jns.2020.116687. Epub 2020 Jan 14.
4
Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.紫杉醇诱导的周围神经病发病机制：使用啮齿动物和人类模型系统的体外和体内研究结果的最新综述。
Exp Neurol. 2020 Feb;324:113121. doi: 10.1016/j.expneurol.2019.113121. Epub 2019 Nov 21.
5
Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.化疗引起的周围神经病（CIPN）的生物学预测因子：MASCC 神经并发症工作组概述。
Support Care Cancer. 2019 Oct;27(10):3729-3737. doi: 10.1007/s00520-019-04987-8. Epub 2019 Jul 30.
6
Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.预测接受密集剂量和含多西他赛辅助化疗的乳腺癌患者毒性的多态性的独立复制。
Oncotarget. 2017 Nov 27;8(69):113531-113542. doi: 10.18632/oncotarget.22697. eCollection 2017 Dec 26.
7
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).夏科-马里-图思病基因ARHGEF10与NCCTG N08CA（联盟）中紫杉醇诱导的周围神经病变的关联。
J Neurol Sci. 2015 Oct 15;357(1-2):35-40. doi: 10.1016/j.jns.2015.06.056. Epub 2015 Jun 27.
本文引用的文献
1
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.对中毒性多发性神经病中的夏科-马里-图什病基因进行测序。
Ann Neurol. 2014 Nov;76(5):727-37. doi: 10.1002/ana.24265. Epub 2014 Sep 17.
2
Detecting rare variant effects using extreme phenotype sampling in sequencing association studies.利用测序关联研究中的极端表型抽样检测罕见变异效应。
Genet Epidemiol. 2013 Feb;37(2):142-51. doi: 10.1002/gepi.21699. Epub 2012 Nov 26.
3
GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients.在斯堪的纳维亚卵巢癌患者中，无法证实基于全基因组关联研究（GWAS）的RWDD3和TECTA基因变异与紫杉醇诱导的神经病变之间的关联。
Acta Oncol. 2013 May;52(4):871-4. doi: 10.3109/0284186X.2012.707787. Epub 2012 Aug 9.
4
Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies.利用极端表型抽样在关联研究中识别数量性状的罕见因果变异。
Genet Epidemiol. 2011 Dec;35(8):790-9. doi: 10.1002/gepi.20628. Epub 2011 Sep 15.
5
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics.药物基因组学时代的化疗诱导性周围神经毒性。
Lancet Oncol. 2011 Nov;12(12):1151-61. doi: 10.1016/S1470-2045(11)70131-0. Epub 2011 Jun 28.
6
Genome-wide association studies for complex traits: consensus, uncertainty and challenges.复杂性状的全基因组关联研究：共识、不确定性与挑战。
Nat Rev Genet. 2008 May;9(5):356-69. doi: 10.1038/nrg2344.
7
Why most published research findings are false.为何大多数已发表的研究结果是错误的。
PLoS Med. 2005 Aug;2(8):e124. doi: 10.1371/journal.pmed.0020124. Epub 2005 Aug 30.
8
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.欧洲癌症研究与治疗组织（EORTC）用于评估化疗引起的周围神经病变的生活质量问卷的研制：QLQ-CIPN20。
Eur J Cancer. 2005 May;41(8):1135-9. doi: 10.1016/j.ejca.2005.02.012. Epub 2005 Apr 14.
Zotero 插件